Fareva
French pharmaceutical company
From Wikipedia, the free encyclopedia
Fareva is a French pharmaceutical company, with annual revenues of $1.6 billion in 2018, founded and 100% owned by Bernard Fraisse, a French billionaire businessman.[2]
 | |
| Company type | Private |
|---|---|
| Founded | 1985 |
| Headquarters | , France |
Key people | Bernard Fraisse, chairman, founder and 100% owner |
| €1.6 billion (2018)[1] | |
Number of employees | 12,500 |
History
It was founded in 1985,[3] and the company now employs 12,500 people.[4] Fareva is the largest contract manufacturing organization (CMO) in France,[5] and of the top five pharmaceutical contract manufacturing organizations in the world. It has over 12,500 employees working in 40 different production sites.[4]
In 2020 the company acquired two biologics facilities from Pierre Fabre; an oncology injectable plant in Pau, Southwest France and a monoclonal antibody (mAb) production facility in Saint-Julien-en-Genevois on the French-Swiss border.[6]
The company is headquartered in Tournon-sur-Rhône, Ardèche, France.[7][8][9]